Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
This guide demonstrates how to leverage historical returns to shape retirement-index-fund allocations and risk management.
21,926 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A new Harvard Law study analyzes whether a safety-focused mission can survive investor pressure as Anthropic prepares...
Bitcoin, Ethereum, and XRP show renewed bullish bias after weeks of pressure, with sentiment turning positive and pri...
A rare bipartisan bill moving through Congress would permanently establish a national AI research resource, reshaping...
XRP fell near $1.08 as big-money moves on the XRP Ledger quieted and ETF flows turned negative, underscoring a cautio...
Three leading tech ETFs battle for AI-era glory. This story breaks down Nvidia exposure, valuation, and risk to answe...
As the 10-year Treasury sits in the low- to mid-4% zone, select dividend stocks more than keep pace with bond returns...
A telecom stock this rose 19% over the past year, but a prominent fund sold out. Discover the drivers behind the move...
This guide digs into plains (pagp) 2026 earnings, translating a complex earnings transcript into practical insights f...
As of mid-May 2026, two retail ETFs diverge sharply: RTH climbs on mega-cap strength, while XRT drifts lower with a b...
A potential hawkish shift in monetary policy could derail the AI stock surge, threatening lofty earnings multiples fo...
Bitcoin steadied near $64,000 after the Fed kept rates unchanged but shifted the outlook toward possible hikes. Marke...